Global Cell Therapy and Gene Therapy CDMO Market Growth (Status and Outlook) 2025-2031
The global Cell Therapy and Gene Therapy CDMO market size is predicted to grow from US$ 5067 million in 2025 to US$ 15700 million in 2031; it is expected to grow at a CAGR of 20.7% from 2025 to 2031.
Key features:
- Cell and Gene Therapy (CGT) is a method of using gene therapy vectors to transduce exogenous therapeutic genes into cells.
- Through external transcription and translation of source genes, CGT changes the original gene expression of cells to treat diseases.
Segmentation by Type:
- Cell Therapy
- Gene Therapy
Segmentation by Application:
- Clinical Stage Projects
- Commercialization Stage Projects
Market by Region:
- Americas: United States, Canada, Mexico, Brazil
- APAC: China, Japan, Korea, Southeast Asia, India, Australia
- Europe: Germany, France, UK, Italy, Russia
- Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries
Company Coverage:
- Lonza Pharmaceuticals
- Thermo Fisher
- catalent
- Jubilant LifeSciences
- Boehringer Ingelheim
- Oxford BioMedica
- Charles River
- WuXi AppTec
- He Yuan Biology
- GenScript Biotech
- Kanglong Chemical
- Porton shares
- Sano Biologics
- Yunzhou Biology
Key Questions Addressed in this Report
Frequently Asked Questions
Cell Therapy and Gene Therapy CDMO report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cell Therapy and Gene Therapy CDMO report is categorised based on following features:
- Global Market Players
- Geopolitical regions
- Consumer Insights
- Technological advancement
- Historic and Future Analysis of the Market
Cell Therapy and Gene Therapy CDMO report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.